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Liver microsomes contain a vitamin K and Oz-dependent carboxylase that converts peptide-bound glutamyl 
residues to y-carboxyglutamyl residues. The peptide Boc-0-phospho-Ser-0-phospho-Ser-Leu-OMe has
now been synthesized. This peptide inhibits the carboxylation of endogenous protein precursors by a 
detergent-solubilized preparation of the carboxylase and is an apparent competitive inhibitor of the 
carboxylation of Phe-Leu-Glu-Glu-Leu. 
Vitamin K Carboxyiase Phosphoserine 
1. INTRODUCTION 
The reduced form of vitamin K is required for 
the action of a liver microsomal enzyme that car- 
boxylates glutamyl residues in precursor proteins 
to y-carboxyglutamyl (Gla) residues in completed 
proteins [l]. This enzyme will carboxylate low-M, 
peptides that are homologous with carboxylated 
sequences in precursor proteins [2]. The results of 
structure-activity studies designed to define the 
substrate specificity of the rat liver vitamin 
K-dependent carboxylase [3] using analogs of sub- 
strate peptides Phe-Leu-Glu-Glu-Leu and Boc- 
Glu-Glu-Leu-OMe clearly indicate that the enzyme 
efficiently carboxylates only L-glutamyl residues. 
A number of lines of evidence [1,4-61 suggest 
that this oxygen-dependent carboxylase activity is 
catalyzed by the same enzyme that converts re- 
duced vitamin K to vitamin K 2,3-epoxide, but the 
detailed mechanism of these reactions has not been 
clarified. These activities are inhibited by vitamin 
K antagonists and a number of non-specific re- 
agents, but specific inhibitors of the glutamyl- 
binding site have not been reported 111. Structure 
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Peptide substrates ycarboxyglutamic acid 
activity data [3] suggest hat for good binding to 
the carboxylase, a peptide must contain an anionic 
group, located two methylene units from the pep- 
tide chain, and that the residue must have the 
L-chirality. This could be achieved by replacing the 
carboxyl group with a phosphate group. We report 
here the synthesis of peptides containing phospho- 
serine residues which, because of the placement of 
an oxygen, rather than a carbon atom at the 
y-position, might be expected to be competitive 
inhibitors of the carboxylase. 
2. EXPERIMENTAL 
2.1. Peptide synthesis 
Melting points were determined on a Fischer- 
Johns melting point apparatus and are corrected. 
Proton nuclear magnetic resonance spectra were 
recorded on a Bruker model Hx90E spectrometer. 
Chemical shifts are reported as values (ppm) rela- 
tive to TMS (tetramethylsilane) as an internal stan- 
dard. Analytical thin-layer chromatography was 1 
carried out using thin-layer chromatography plates 
precoated with silica gel 60F-254. Spots were visua- 
lized as in [3]. Solvent systems used were: (1) 6% 
methanol in chloroform; 95% ethanol; (3) 15% 
methanol in chloroform; (4) methanol; (5) 
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Fig. 1. General scheme for the synthesis of peptides con- 
taining phosphoserine r sidues. 
chloroform-methanol-acetic acid (70 : 25 : 5), and 
(6) 10% methanol in chloroform. Boc-Ser-Leu- 
OMe (IV) (m.p. 143-144°C; Rf(l) = 0.31 
Rf(2) = 0.76), Boc-Ser-Ser-Leu-OMe (V) 
(Rf(3) = 0.45) and Boc-Phe-Leu-Ser-Ser- 
Leu-OMe (m.p. 184°C; Rf(3)=0.54) were syn- 
thesized from Leu-OMe (II) and Boc-Ser 
dicyclohexylamine salt (III) using methods reported 
for the synthesis of related analogs [3]. Details of 
these syntheses will be reported separately, and the 
general synthesis cheme utilized is shown in fig. 1. 
2.2. 0-Phosporylation of(V) (VI) 
Compound (V) (420.0 mg, 0.001 mol) was dissol- 
ved in 20 ml of methylene chloride and triethylamine 
(0.422 ml, 0.003 mol) was added. After 10 min, di- 
phenyl chlorophosphate (0.622 ml, 0.003 mol) was 
added and the mixture was stirred at 0°C for 1 h 
and at room temperature for 2 days. After 
evaporation of solvent, the residue was purified by 
silica gel chromatography eluting with 1% metha- 
nol in chloroform to give 814.0 mg (92.1%) of (VI) 
as an oil: Rf(1) = 0.69. ‘H NMR (CDC13) 0.85 (d, 
6H, J= 5.8 Hz, Leu 2 -CH3) 1.42 (s, 9H, Boc) 
1.59-1.68 (m, 3H, Leu&CH2, y-CH) 3.68 (s, 3H, 
Leu-OCH3) 4.29-4.91 (m complex, 7H, 3~CH, 
2Ser,&CH2) 5.63 (d, lH, J= 6.0 Hz, NH) 7.04-7.51 
(m, 22H, 4 Aromatic, 2NH). This material under- 
goes rapid &elimination and was converted im- 
mediately to the free phosphate derivative I. 
2.3. Boc-O-phospho-Ser-O-phospho-Ser- 
Leu-OMe (I) 
Compound (VI) (707.2 mg, 0.8 mmol) was dis- 
solved in 40 ml of dry methanol, platinum oxide 
(PtO2, 500 mg) was added, and the mixture was 
hydrogenated for 12 h. After removal of the cata- 
lyst by filtration, new catalyst (200 mg) was added 
and the mixture hydrogenated again for 8 h. The 
solution was filtered through a celite 545 column 
and evaporated to dryness. The residue was recrys- 
tallized from 1.5 ml methanol and 30 ml ether to 
give 192.0 mg (41.7%) of crystalline I: m.p. 
174-176°C. Rf(4) = 0.28. ‘H NMR (MeOH-&) 
6 = 0.93 (br, s, 6H, Leu 2 -CH3) 1.45 (s, OH, Boc) 
1.60-l .82 (br, 3H, Leu ,&CH2, y-CH) 3.70 (s, 3H, 
Leu-OCH3) 4.08-4.27 (br, 4H, 2Ser ,&CH2) (r-CH 
region (overlapped with MeOH peak). Anal. talc. 
for C~~HJ~N~O~~PZ: C, 37.31; H, 6.09; N, 7.25. 
Found: C, 37.50; H, 5.98; N, 7.14. Using the pro- 
cedures described for the synthesis of VI and I, 
Boc-Phe-Leu-Ser-Ser-Leu-OMe was bis-phos- 
phorylated (m.p. 139-140°C; Rf(6) = 0.71) and 
hydrogenated to Boc-Phe-Leu-phospho-Ser- 
phospho-Ser-Leu-OMe (VII): Rr(5) = 0.05; ‘H 
NMR is the same as obtained for I except for the 
added signals for the Phe and Leu residues. 
2.4. Carboxylase assays 
Vitamin K-dependent carboxylase activity was 
assayed in stored liver microsomes prepared from 
vitamin K-deficient rats. Incorporation of 14C02 
into the peptide substrate Phe-Leu-Glu-Glu-Leu 
(peptide carboxylase activity) was measured as in 
[3] and into endogenous microsomal protein (pro- 
tein carboxylase activity) as in [7]. Peptides being 
assayed for inhibitor activity were dissolved in a 
small amount of resuspension buffer [3] containing 
5% Triton X-100 before being added to incubation 
tubes. The substrate Phe-Leu-Glu-Glu-Leu was 
obtained from Bachem (Torrance, CA). Other re- 
agents used were obtained as indicated in cited 
procedures. 
3. RESULTS 
The synthesized peptides Boc-Ser-Ser-Leu-OMe 
(V), Boc-O-phospho-Ser-O-phospho-Ser-Leu- 
OMe (I), and Boc-Phe-Leu-O-phospho-Ser-O- 
phospho-Ser-Leu (VII) were assayed as substrates 
for the vitamin K-dependent carboxylase at 0.5 and 
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Fig.2. Effect of other peptides on the vitamin K-depen- 
dent carboxylation of Boc-Glu-Glu-Leu-OMe (left), 
or endogenous protein precursors (right): (G---O) Boc- 
Ser-Ser-Leu-OMe; (M) Boc-O-phospho-Ser-O- 
phospho-Ser-Leu-OMe; (W-U) Boc-Phe-Leu-O- 
phospho-Ser-0-phospho-Ser-Leu. 
2.5 mM. No 14C02 incorporation into these pep- 
tides was observed. When these compounds were 
tested for their ability to inhibit carboxylation of 
other substrates, the data in fig.2 were obtained. 
All 3 compounds inhibited the carboxylation of 
both an added peptide substrate and endogenous 
protein precursors. In both cases, the non-anionic 
Ser-containing peptide was a relatively weak in- 
hibitor, while the phosphoserine-containing com- 
pounds were more effective. The strongest inhibi- 
tion was exhibited by the close analog of the 
pentapeptide substrate, compound VII. Inhibition 
of the added peptide substrate was more substan- 
tial than the endogenous protein. 
The structural similarity of the phosphoserine- 
containing peptides to substrates of the enzyme 
suggest hat these compounds may act as competi- 
tive inhibitors at the Glu binding site of the enzyme. 
This was investigated in more detail utilizing com- 
pound I as an inhibitor of the carboxylation of 
Phe-Leu-Glu-Glu-Leu. The double reciprocal 
plot shown in fig.3 is consistent with the action of 
compound I as a competitive inhibitor of this sub- 
strate, and the slope replot data in the insert sug- 
gest a Ki of -4 mM. The reversible nature of the 
inhibition was checked by dialysis of the completely 
resuspended microsomes plus 5 mM compound I 
for 30 min or 12 h against the resuspension buffer 
before the standard assay was carried out. A 30 min 
dialysis was sufficient to reverse the inhibition of 
I/ [Phe-Leu-Glu-Glu-Leu],mM 
Fig.3. Double reciprocal plot of the effects of Boc-O- 
phospho-Ser-0-phospho-Ser-Leu-OMe on the vitamin 
K-dependent carboxylation of Phe-Leu-Glu-Glu-Leu. 
Inhibitor concentrations used were: 1.25 mM (H); 
2.5 mM (W-O); 5.0 mM (t&-O); and 10.0 mM 
(@+I). A replot of the slope is shown in the insert. 
protein carboxylation and decrease the inhibition 
of peptide carboxylation. A 12-h dialysis decreased 
the inhibition of peptide carboxylation by com- 
pound I to < 10%. 
4. DISCUSSION 
A number of inhibitors of the detergent-solu- 
bilized vitamin K-dependent carboxylase have been 
described in [I]. These have included vitamin K 
analogs such as Chloro-K [8], 2,3,5,6-tetrachloro- 
4-pyridinol [9, IO], reduced vitamin K esters [l l] 
and a series of substituted forms of vitamin K 
[12,13]. Some thiol-reactive agents [15,16] and spin 
trapping reagents [ 151 and superoxide dismutase 
[16,17] have also been reported to inhibit this en- 
zyme. Relatively high concentrations of cyanide in- 
hibit the carboxylation reaction [ 181. This response 
is at least partially competitive with respect o CO2 
[19] but other effects may be involved [S]. 
Specific inhibitors of the Glu binding site have 
not yet been described. A large number of peptides 
which contained Asp, homo-Glu, Gln or D-Glu 
residues which were not efficient substrates for the 
carboxylase were not found to be inhibitors of the 
reaction [3]. A cyclic hexapeptide which contains a 
disulfide bridge corresponding to bovine prothrom- 
bin precursor sequence 18-23 has been reported to 
inhibit carboxylation of Phe-Leu-Glu-Glu-Leu 
[20], but the nature of this inhibition has not been 
81 
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described. The peptides reported here, which con- 
tain phosphoserine rather than glutamyl residues, 
appear to satisfy the criteria of competitive inhibi- 
tors of the Glu binding site and should be useful 
probes of the mechanism of action of this multi- 
substrate unique carboxylase. 
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